Answers are grounded in this paper and cite their sources.
To clarify whether post-procedural administration of protease inhibitor can reduce the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis as effectively as pre-procedural administration.
No takes yet. Share an insight, caveat, or question.
Kei Ito (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: